Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model - Wikidata - wikimedia - TriplyDB

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

http://www.wikidata.org/entity/Q34238364

about

Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols.Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy Estimation of α/β for late rectal toxicity based on RTOG 94-06 Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol Types of chronic conditions combinations and initial cancer treatment among elderly Medicare beneficiaries with localised prostate cancer.Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.Reducing rectal injury during external beam radiotherapy for prostate cancer.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer Treatment planning evaluation and optimization should be biologically and not dose/volume based.Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer.Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects.Variations in Rectal Volumes and Dosimetry Values Including NTCP due to Interfractional Variability When Administering 2D-Based IG-IMRT for Prostate Cancer

P2860

Q30664267-5FEEE52F-8F30-413B-B8FB-AB38866A28F4 Q34161145-66EC60EE-0D5C-4FFE-BAFC-3A2231E5388A Q34258742-92A174D1-A4E2-41A3-A5A7-C28C26ECCD98 Q34771688-4078C65F-42DD-4383-9812-C09E8505122B Q35186584-0545A61A-65D7-4399-9A27-FD9CE93FCF24 Q35500065-51FA17B6-3E6F-4E1C-9FC6-7759B6384DA4 Q36011188-4B1E31B6-CBC0-4015-A9B5-87564D94E9E0 Q36145910-9CA1786C-18D5-4CA5-955A-AD3316089A65 Q36465589-FE85F245-0DCF-42AD-97B2-19C585B1E60C Q36922615-3138AB96-0B11-41FD-9526-FD163E8E8521 Q37053006-F146277F-06E0-4047-AA29-E2759A9F4D5D Q37633737-44A77BD9-CE6B-4BC5-9E8E-479DBA9D1CFF Q38106626-93ADEA06-3EFB-4605-9D20-06B1F21C7623 Q38981805-0DEF24BE-02D5-42F2-93BB-004FCBEC7960 Q40721973-617089AE-1B9C-4C69-9E02-0E0A7730D82B Q45213721-6220CA4A-EE04-4A42-9E48-AE6425BF737D Q45240634-EC77E535-CFCC-450B-A694-77C5013480AA Q47684929-7BD0FEDE-6298-475E-8B50-61799D437BE2 Q59049383-7F303F91-144A-47E0-B3D1-031BF1314107

P2860

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

http://www.wikidata.org/entity/Q34238364

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@ast

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@en

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@nl

type

label

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@ast

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@en

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@nl

prefLabel

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@ast

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@en

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@nl

P1433

Q34238364-5D0486D4-598E-402E-AE47-DAD165234895

P1476

Q34238364-1894EFD7-1D91-4233-B5F0-6AD2CE9B5D10

P2093

Q34238364-0CF8644B-35C0-4EF9-838C-D2D7CF97EAEA

Q34238364-0EA65CB4-A4CF-4A64-BA04-F649CD6E2D10

Q34238364-15DCA8EA-BEE0-4826-BE66-22972D130B66

Q34238364-27C0F820-D6B1-4156-AD50-30866C345953

Q34238364-3264D353-AF82-4C2E-99C5-9EB156A618C4

Q34238364-4ED305C3-6CD3-45F1-BC9C-7E2FE3B7F043

Q34238364-53F4743A-EE26-4F2C-B180-8D2966884B30

Q34238364-6C889FE4-D115-4DF4-B1D8-87099DE7BF12

Q34238364-751BBB7A-543B-44C7-B4AD-37948F5F7639

Q34238364-B6056045-0BEF-44F6-9956-C759C54F183E

P2860

Q34238364-027EEDDB-8485-4534-B484-D26ED1DB7A0D

Q34238364-1C210FB6-7A09-4BC3-A4A5-23D94D6FA3D7

Q34238364-2398C795-BDAE-4DB5-B562-2813799659FB

Q34238364-29A39143-6EAA-44F2-9932-A0B6B18DD0F9

Q34238364-2B3EDDAD-F764-4A24-A957-418E2B62D9DD

Q34238364-5541ED96-9DC7-41AF-858C-A38DD53C5735

Q34238364-70B1B7B9-8AA8-4F38-ADC7-87E4283C5B0C

Q34238364-71BC8D78-70F8-4466-8165-8622833579B2

Q34238364-76879D19-1FB6-4BC7-A631-BA542C3AC1BF

Q34238364-7BAAABA4-1E19-4EA9-AE39-C969F5028238

P304

Q34238364-94EBA661-169D-4C53-BD7E-75389D785FF7

P31

Q34238364-275666FB-C9D0-458D-9C19-8A6AB9A7D396

P356

Q34238364-AB7A3C20-CCCE-4E83-876A-0EDA0A7F99CB

P407

Q34238364-5F5246F9-5E02-4CB4-A2EE-4AA7467D4D71

P433

Q34238364-DE9196E5-5C3B-4F66-97F3-67B0D6845D8E

P478

Q34238364-423AD323-738D-410E-8242-D6EC94C276BA

P50

Q34238364-B96E6325-1870-42BB-BD1B-5BC39B1BDDDA

P577

Q34238364-E46D1C23-94C5-4952-A0AD-7E28369D71AB

P5875

Q34238364-1B8AD15C-60D6-440B-8CA7-6F71D917A430

P698

Q34238364-FA980218-0038-43A1-A57A-75BFA0C17D8A

P932

Q34238364-36BC8096-616E-4F75-801B-68181372E5E5

P356

J.IJROBP.2010.01.069

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

@en

P2093

Andrew K Lee

http://www.w3.org/2001/XMLSchema#string

Deborah Kuban

http://www.w3.org/2001/XMLSchema#string

Howard D Thames

http://www.w3.org/2001/XMLSchema#string

James A Purdy

http://www.w3.org/2001/XMLSchema#string

James D Cox

http://www.w3.org/2001/XMLSchema#string

Jeff Michalski

http://www.w3.org/2001/XMLSchema#string

Kathryn Winter

http://www.w3.org/2001/XMLSchema#string

Lei Dong

http://www.w3.org/2001/XMLSchema#string

M Rex Cheung

http://www.w3.org/2001/XMLSchema#string

Susan L Tucker

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating and modeling the cure fraction in population-based cancer survival analysis

Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Radiation dose-volume effects in radiation-induced rectal injury.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Analysis of radiation pneumonitis risk using a generalized Lyman model.

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

Diabetes mellitus: a predictor for late radiation morbidity.

Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

P304

1253-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2010.01.069

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45089949

http://www.w3.org/2001/XMLSchema#string

P698

20598811

http://www.w3.org/2001/XMLSchema#string

P932

2963659

http://www.w3.org/2001/XMLSchema#string